We are live on ! Find out more
LCC

Lincoln Capital Corp Portfolio holdings

AUM $308M
1-Year Est. Return 24.88%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+24.88%
3 Year Est. Return
+73.88%
5 Year Est. Return
+87.55%
10 Year Est. Return
AUM
$117M
AUM Growth
+$5.26M
Cap. Flow
-$1.67M
Cap. Flow %
-1.42%
Top 10 Hldgs %
49.98%
Holding
54
New
9
Increased
13
Reduced
25
Closed
4

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.68M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.16M
3
MRK icon
Merck
MRK
+$1.73M
4
KR icon
Kroger
KR
+$1.53M
5
SJM icon
J.M. Smucker
SJM
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Technology 14.32%
3 Financials 12.43%
4 Industrials 9.49%
5 Energy 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHP icon
1
Schwab US TIPS ETF
SCHP
$16.3B
$9.96M 8.5%
359,474
+12,364
+4% +$342K
MSFT icon
2
Microsoft
MSFT
$2.84T
$7.44M 6.35%
86,977
-5,541
-6% -$455K
TXT icon
3
Textron
TXT
$16.6B
$6.77M 5.78%
119,653
-2,052
-2% -$112K
FLRN icon
4
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$6.06M 5.17%
197,655
-11,522
-6% -$354K
SCHA icon
5
Schwab U.S Small- Cap ETF
SCHA
$22.5B
$5.33M 4.55%
305,764
+266,036
+670% +$4.55M
SCHB icon
6
Schwab US Broad Market ETF
SCHB
$42.8B
$5.05M 4.31%
469,932
-25,068
-5% -$263K
JNJ icon
7
Johnson & Johnson
JNJ
$635B
$4.74M 4.05%
33,937
+143
+0.4% +$19.9K
ABT icon
8
Abbott
ABT
$180B
$4.62M 3.94%
80,893
+745
+0.9% +$41.3K
ABBV icon
9
AbbVie
ABBV
$458B
$4.43M 3.78%
45,783
-3,578
-7% -$337K
BNY
10
Bank of New York Mellon
BNY
$108B
$4.14M 3.54%
76,961
-2,242
-3% -$119K
ORCL icon
11
Oracle
ORCL
$331B
$4.14M 3.54%
87,634
-914
-1% -$44.8K
MET icon
12
MetLife
MET
$61B
$3.83M 3.27%
75,675
-271
-0.4% -$14.3K
JPM icon
13
JPMorgan Chase
JPM
$939B
$3.76M 3.21%
35,161
-932
-3% -$94.4K
COP icon
14
ConocoPhillips
COP
$147B
$3.16M 2.69%
57,503
+317
+0.6% +$16.3K
AMGN icon
15
Amgen
AMGN
$203B
$3.1M 2.65%
17,844
-636
-3% -$113K
SCHV
16
Schwab US Large-Cap Value ETF
SCHV
$15.8B
$3.08M 2.63%
+169,074
New +$3.01M
CELG
17
DELISTED
Celgene Corp
CELG
$3.07M 2.62%
29,375
-2,501
-8% -$282K
NOBL icon
18
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$2.75M 2.35%
85,836
+602
+0.7% +$18.6K
NXPI icon
19
NXP Semiconductors
NXPI
$68B
$2.7M 2.3%
23,029
-18,694
-45% -$2.16M
TNL icon
20
Travel + Leisure Co
TNL
$4.54B
$2.31M 1.97%
44,063
+4,742
+12% +$235K
GE icon
21
GE Aerospace
GE
$367B
$2.28M 1.95%
27,274
-12,372
-31% -$1.18M
SLB icon
22
SLB Ltd
SLB
$77.8B
$2.13M 1.82%
31,603
+5,045
+19% +$327K
MRK icon
23
Merck
MRK
$324B
$1.98M 1.69%
36,776
-31,176
-46% -$1.73M
APA icon
24
APA Corp
APA
$12.8B
$1.72M 1.47%
40,821
-7,282
-15% -$306K
KSU
25
DELISTED
Kansas City Southern
KSU
$1.67M 1.42%
15,849
-9,153
-37% -$976K

Similar funds

Lincoln Capital Corp's Q4 2017 Portfolio in Review

As of Q4 2017, Lincoln Capital Corp held 54 positions worth $117M, up 4.7% from $112M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Lincoln Capital Corp's Q4 2017 filing shows 9 new, 13 increased, 25 reduced and 4 closed positions. Its largest new stake was Schwab US Large-Cap Value ETF: 169,074 shares worth $3.08M. The largest sale was CVS Health, an estimated $3.68M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Lincoln Capital Corp's largest Q4 2017 buy was Schwab US Large-Cap Value ETF: 169,074 shares worth $3.08M.
  • Lincoln Capital Corp added most to Schwab U.S Small- Cap ETF in Q4 2017, an estimated $4.55M increase.
  • Lincoln Capital Corp's biggest Q4 2017 reduction was NXP Semiconductors, cutting an estimated $2.16M.
  • Lincoln Capital Corp fully exited CVS Health in Q4 2017, selling an estimated $3.68M.
  • Lincoln Capital Corp's ten largest holdings make up 50% of its $117M portfolio in Q4 2017.
  • Lincoln Capital Corp opened 9 new positions and closed 4 in Q4 2017.
  • Lincoln Capital Corp's portfolio value rose 4.7% quarter-over-quarter to $117M.

Based on Lincoln Capital Corp's 13F filing for Q4 2017, filed 6 Feb 2018.